PODXL enhances the extravasation through direct binding to ezrin, a cytoskeletal linker protein, which enables the transition of tumor cells from a non-polarized, rounded cell shape to an invasive extravasation-competent morphology [29]. The gene discussed is PODXL; the disease is neoplasm.